Related Experiment Video
Updated: May 16, 2025

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
Published on: February 12, 2016
Expression of miRNA-338-3p/miRNA-1250-5p/miRNA-3065-5p clusters in peripheral blood mononuclear cells of ischemic
Tingting Feng1, Lizhen Wang1, Ruijiao Zhou1
1Department of Neurology, Affiliated Hospital of North Sichuan Medical College, Sichuan, China.
Abstract:
To estimate the correlation between miRNA-338-3p/miRNA-1250-5p/miRNA-3065-5p clusters and ischemic stroke (IS). 83 hospitalized patients diagnosed with IS (experimental group) and 50 healthy subjects (control group) were enrolled in the Affiliated Hospital of North Sichuan Medical College from July 2020 to December 2020. The levels of miRNA-338-3p, miRNA-1250-5p, and miRNA-3065-5p in peripheral blood mononuclear cells (PBMCs) were measured by real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR). The expressions of miRNA-1250-5p and miRNA-3065-5p were significantly higher in the experimental group compared to the control group (2.04 ± 0.22 vs. 1.54 ± 0.33, P = 0.002, 6.41 ± 2.17 vs. 1.42 ± 0.24, P < 0.001, respectively) No significant difference in miRNA-338-3p expression was observed between the experimental and control groups (1.87 ± 0.22 vs. 1.25 ± 0.11, P = 0.309). The expression levels of miRNA-1250-5p increased after 24 h and no more than 7 days of disease progression but decreased after 7 days compared to baseline (P < 0.05). The expression levels of miRNA-3065-5p and miRNA-338-3p in patients with a discharge National Institutes of Health Stroke Scale (NIHSS) score greater than 33 were higher than those in the group with a score of 3 or less (P < 0.05). Additionally, the expression level of miRNA-3065-5p in patients with discharged mRS scores of 3 or higher was greater than in patients with discharged mRS scores of 2 or lower (P < 0.05). The miRNA-338-3p/miRNA-1250-5p/miRNA-3065-5p clusters showed a positive correlation with neutrophil percentage and a negative correlation with lymphocyte percentage (P < 0.05). Furthermore, miRNA-338-3p, miRNA-1250-5p, and miRNA-3065-5p significantly correlated in IS (P < 0.001). miRNA-1250-5p and miRNA-3065-5p may be associated with IS.
Insights
MicroRNA-1250-5p and microRNA-3065-5p show elevated levels in patients with ischemic stroke (IS). These microRNAs, along with microRNA-338-3p, correlate with disease severity and immune cell percentages in IS patients.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Ischemic stroke (IS) is a leading cause of long-term disability and mortality worldwide.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are implicated in various diseases, including stroke.
- Specific miRNA clusters may serve as potential biomarkers for IS diagnosis and prognosis.
Purpose of the Study:
- To investigate the correlation between the miRNA-338-3p/miRNA-1250-5p/miRNA-3065-5p clusters and ischemic stroke (IS).
- To assess the relationship between these miRNA levels and clinical parameters, including stroke severity and immune cell profiles.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) were collected from 83 IS patients and 50 healthy controls.
- Real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR) was used to measure the expression levels of miRNA-338-3p, miRNA-1250-5p, and miRNA-3065-5p.
- Statistical analyses were performed to correlate miRNA expression with IS diagnosis, disease progression (NIHSS scores), and immune cell percentages.
Main Results:
- Expression of miRNA-1250-5p and miRNA-3065-5p was significantly higher in IS patients compared to controls.
- No significant difference in miRNA-338-3p expression was found between groups.
- miRNA-1250-5p levels fluctuated during the early stages of IS, while miRNA-3065-5p and miRNA-338-3p levels correlated with higher NIHSS and mRS scores.
- The miRNA cluster positively correlated with neutrophil percentage and negatively with lymphocyte percentage.
- All three miRNAs showed significant inter-correlation in IS patients.
Conclusions:
- miRNA-1250-5p and miRNA-3065-5p may be potential biomarkers associated with ischemic stroke.
- The expression patterns of these miRNAs suggest a role in the inflammatory response and disease progression in IS.
- Further research is warranted to elucidate the precise mechanisms and clinical utility of these miRNA clusters in IS management.
More Related Videos
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
12:42Stereological and Flow Cytometry Characterization of Leukocyte Subpopulations in Models of Transient or Permanent Cerebral Ischemia
Published on: December 28, 2014